Induction Immunotherapy Followed by Thoracic Radiation without Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Case Series

OBJECTIVE: Although concurrent chemoradiation has been the standard of care for unresectable stage III non-small cell lung cancer (NSCLC) due to increased survival and decreased disease progression, patients with poor performance status cannot tolerate chemotherapy toxicity well. Durvalumab, an immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dasari, Srikiran, Komiya, Takefumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258669/
https://www.ncbi.nlm.nih.gov/pubmed/35092391
http://dx.doi.org/10.31557/APJCP.2022.23.1.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258669/
https://www.ncbi.nlm.nih.gov/pubmed/35092391
http://dx.doi.org/10.31557/APJCP.2022.23.1.217

Ejemplares similares